Syphilis Immunoassay Diagnostics Market - Global Industry Analysis

Syphilis Immunoassay Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Medical Device Report Format : PDF Report Code: ZMR-6512 Status : Upcoming

Description

Global Syphilis Immunoassay Diagnostics Market: Overview

Syphilis is a chronic bacterial disease that is spread by sexual activity. It can be cured with antibiotics, especially in the early stage. It is a sexually transmitted infection spread by bacteria named, Treponema pallidum that possesses long-term complications if not diagnosed and treated early. The disease is diagnosed with the help of serology testing and clinical findings. The serological diagnosis of syphilis includes the identification and detection of different kinds of antibodies namely, non-treponemal and treponemal antibodies. The syphilis prototype is reallocated around several centers to diagnose the treponemal antibody test if there is a positive test report for treponemal antibody. There are different types of methods utilized for its diagnoses, including enzyme immunoassay (EIA) test, venereal disease research laboratory (VDRL) test, RPR test, and others. The diagnosis of syphilis depends on the level of clinical suspicion and routine screening for the patients at higher risk.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Syphilis Immunoassay Diagnostics Market: Growth Factors

Syphilis is a global health concern due to its constantly growing incidences, particularly among bisexual and gay people. Thereby, it is likely to fuel the growth of the global syphilis immunoassay diagnostics market during the forecast period. However, the growing cases of anonymous sex, sex under the influence of dangerous drugs, sex with multiple partners, and also the growing number of unprotected sex both oral & anal will complement the growth of the market. Also, there is significant prominence of syphilis in pregnant women due to sexual intercourse with infected partners which leads to congenital abnormalities like stillbirth and other complications in pregnancy. The ongoing technological advancements in analyzer technology are likely to create several lucrative growth opportunities in the field of syphilis immunoassay diagnostics. However, the surge in the demand for analyzers in blood banks and hospitals is likely to further boost the growth of the global syphilis immunoassay diagnostics market during the forecast period. The utilization of several advanced computing techniques like artificial intelligence and machine learning in laboratory diagnosis will facilitate a high level of accuracy and high-quality testing facility. The manufacturers are enhancing their testing abilities with innovative software to improve the testing facility. There is a significant surge in the trend of on-the-spot testing, which in turn will drive the growth of the market.

Global Syphilis Immunoassay Diagnostics Market: Segmentation

The global syphilis immunoassay diagnostics market can be segmented into end-user, product, type, technology, and region.

By end-user, the market can be segmented into diagnostic labs, blood banks, hospitals, and others. The diagnostic lab segment dominates the global syphilis immunoassay diagnostics market.

By product, the market can be segmented into kits, reagents, analyzers, and others.

By type, the market can be segmented into secondary syphilis and primary syphilis.

By technology, the market can be segmented into enzyme-linked immunosorbent assay and chemiluminescence immunoassay. The chemiluminescence immunoassay segment accounts for the largest share in the global syphilis immunoassay diagnostics market due to the lower turnaround and higher efficiency.

Global Syphilis Immunoassay Diagnostics Market: Regional analysis

North America accounts for the largest share in the global syphilis immunoassay diagnostics market due to the adoption of advanced technology for screening tests along with growing initiatives from the government to lower the growing incidences of syphilis infections in the region. Furthermore, the growing awareness among people regarding the early diagnosis and treatment of syphilis will further escalate the growth of the regional market.

Asia Pacific is expected to witness a significant growth rate in the forthcoming years due to the ongoing technological advancements in diagnostic technology in the region.

Global Syphilis Immunoassay Diagnostics Market: Competitive Players

Some of the significant players in the global syphilis immunoassay diagnostics market are Hoffmann-La Roche Ltd, Fujirebio, bioMérieux SA, DiaSorin S.p.A., Shenzhen New Industries Biomedical Engineering Co., Ltd., Ortho Clinical Diagnostics, Abbott Laboratories, F. Dickinson and Company, Becton, Danaher, Siemens Healthineers AG, and Bio-Rad Laboratories, Inc.

Global Syphilis Immunoassay Diagnostics Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content


Frequently Asked Questions

Syphilis is a global health concern due to its constantly growing incidences, particularly among bisexual and gay people. Thereby, it is likely to fuel the growth of the global syphilis immunoassay diagnostics market during the forecast period. However, the growing cases of anonymous sex, sex under the influence of dangerous drugs, sex with multiple partners, and also the growing number of unprotected sex both oral and anal will complement the growth of the market.

Some of the significant players in the global syphilis immunoassay diagnostics market are Hoffmann-La Roche Ltd, Fujirebio, bioMérieux SA, DiaSorin S.p.A., Shenzhen New Industries Biomedical Engineering Co., Ltd., Ortho Clinical Diagnostics, Abbott Laboratories, F. Dickinson and Company, Becton, Danaher, Siemens Healthineers AG, and Bio-Rad Laboratories, Inc.

 

North America accounts for the largest share in the global syphilis immunoassay diagnostics market due to the adoption of advanced technology for screening tests along with growing initiatives from the government to lower the growing incidences of syphilis infections in the region.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social